CARY, N.C., Dec. 20, 2011 /PRNewswire/ -- Cetero Research, the leading early-stage contract research organization, today announced two new appointments to its senior management team. Michael C. Fillios was named Chief Administrative Officer, with leadership responsibility and oversight of Human Resources, Information Technology, Project Management, Marketing and Client Services. David Coggin was named Vice President, Biometrics. He will oversee the operational management of PK/PD, Data Management, Biostatistics and Medical Writing Services. Both positions report directly to Chief Executive Officer Troy W. McCall, Ph.D.
Mr. Fillios is a 21-year veteran of industries spanning pharmaceutical manufacturing, industrial engineering and management consulting. He was most recently responsible for strategic business relationship management and process, as well as enterprise technology integration and all global business functions at ITT Corporation, a global high-tech engineering and manufacturing company.
Mr. Coggin has nearly 30 years of experience in the pharmaceutical and clinical research industries. He most recently held the role of Global Head, Early Clinical Services, Clinical Data Management, within the Clinical Data, Analysis and Reporting Organization at Covance. He has held leadership positions at Covance for the past 17 years, where he was responsible for the overall performance of biostatistics, data management, medical writing and programming services.
"Michael brings a diverse background in organizational transformation, strategic management, and business process optimization across multiple industries," said Dr. McCall. "Furthermore, David's extensive knowledge of clinical development and scientific expertise will serve Cetero well as we continue to explore and offer streamlined development approaches. Both of these accomplished leaders will help us realign infrastructure and integrate service offerings to meet the evolving needs of our customers."
Mr. Fillios has a Bachelor of Business Administration degree from The Hagen School of Business at Iona College.
Mr. Coggin earned his Bachelor of Science degree in entomology from the University of Delaware. He holds a Master of Business Administration degree from Hood College, a Master of Computer Science from the Johns Hopkins University and a Master in Entomology with emphasis in biostatistics from the University of Maryland.
About Cetero Research
Cetero Research, the leading early-stage contract research organization, has conducted more than 20,000 clinical pharmacology studies - more than any other CRO. With facilities across North America, Cetero offers flexible, high-quality clinical development services in a range of therapeutic areas, including asthma and allergy, dermatology and diabetes, as well as bioanalytical services to support preclinical, clinical, drug and biomarker analysis for small and large molecules. It uses innovative approaches, such as the Accelerated Proof-of-Concept study design to provide key decision-making data earlier in the development process. For more information, visit Cetero.com or call 877.7CETERO.
SOURCE Cetero Research